Local injection of adalimumab for perianal Crohn's disease: better than infliximab?
Poggioli
G
G
Laureti
S
S
Pierangeli
F
F
Bazzi
P
P
Coscia
M
M
Gentilini
L
L
Gionchetti
P
P
Rizzello
F
F
D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D001004:Anus Diseases / Q000188:drug therapy* / Q000473:pathology; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000069285:Infliximab; D007267:Injections; D011379:Prognosis; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab